OHE: Publications http://www.ohe.org/object/display.cfm?serv=2 OHE - Office of Health Economics Thu, 23 May 2013 08:35:27 GMT Willingness to Pay and Publicly Funded Health Care http://www.ohe.org/object/display.cfm?serv=2&id=101#101 101 Wed, 30 Nov 2011 00:00:00 GMT Summary Report of the OHE/EFPIA Antibacterial Roundtable http://www.ohe.org/object/display.cfm?serv=2&id=97#97 97 Tue, 15 Nov 2011 00:00:00 GMT The Effect of Payment on GPs' Motivation http://www.ohe.org/object/display.cfm?serv=2&id=96#96 96 Mon, 14 Nov 2011 00:00:00 GMT Using Happiness to Value Health http://www.ohe.org/object/display.cfm?serv=2&id=98#98 98 Tue, 08 Nov 2011 00:00:00 GMT Health and the Use of Medicines in Primary Care in Wales http://www.ohe.org/object/display.cfm?serv=2&id=99#99 99 Tue, 01 Nov 2011 00:00:00 GMT Operationalising Value Based Pricing of Medicines http://www.ohe.org/object/display.cfm?serv=2&id=1#1 1 Sat, 06 Aug 2011 23:00:00 GMT OHE Guide to UK Health and Health Care Statistics http://www.ohe.org/object/display.cfm?serv=2&id=2#2 2 Sat, 30 Jul 2011 23:00:00 GMT Achieving World Class Outcomes in Cancer Treatment http://www.ohe.org/object/display.cfm?serv=2&id=3#3 3 Wed, 20 Jul 2011 23:00:00 GMT Is the Aim of the Health Care System to Maximise QALYs? http://www.ohe.org/object/display.cfm?serv=2&id=4#4 4 Sun, 15 May 2011 23:00:00 GMT New Drugs to Tackle Antimicrobial Resistance http://www.ohe.org/object/display.cfm?serv=2&id=5#5 5 Fri, 29 Apr 2011 23:00:00 GMT Exploring the Interdependency between Public and Charitable Medical Research http://www.ohe.org/object/display.cfm?serv=2&id=6#6 6 Tue, 19 Apr 2011 23:00:00 GMT Incentives for R&D for New Antimicrobial Drugs http://www.ohe.org/object/display.cfm?serv=2&id=7#7 7 Sun, 03 Apr 2011 23:00:00 GMT Incorporating Multiple Criteria in HTA: Methods and Processes http://www.ohe.org/object/display.cfm?serv=2&id=8#8 8 Tue, 29 Mar 2011 23:00:00 GMT Managing Poorly Performing Clinicians http://www.ohe.org/object/display.cfm?serv=2&id=9#9 9 Mon, 28 Mar 2011 23:00:00 GMT Pharmaceutical Pricing in Europe http://www.ohe.org/object/display.cfm?serv=2&id=10#10 10 Tue, 01 Feb 2011 00:00:00 GMT The Evolution of HTA in Emerging Markets http://www.ohe.org/object/display.cfm?serv=2&id=100#100 100 Wed, 05 Jan 2011 00:00:00 GMT Priority Review Vouchers for Neglected Diseases http://www.ohe.org/object/display.cfm?serv=2&id=11#11 11 Sat, 01 Jan 2011 00:00:00 GMT A Comparison of Alternative Variants of TTO http://www.ohe.org/object/display.cfm?serv=2&id=12#12 12 Fri, 24 Dec 2010 00:00:00 GMT Science Policy Research: Having an Impact on Policy? http://www.ohe.org/object/display.cfm?serv=2&id=14#14 14 Wed, 01 Dec 2010 00:00:00 GMT Biosimilars: How Much Entry and Price Competition Will Result? http://www.ohe.org/object/display.cfm?serv=2&id=13#13 13 Wed, 01 Dec 2010 00:00:00 GMT Assessment of the Impact of Orphan Medicinal Products on Europe http://www.ohe.org/object/display.cfm?serv=2&id=15#15 15 Sat, 20 Nov 2010 00:00:00 GMT Shedding the Pounds: Obesity Management in England http://www.ohe.org/object/display.cfm?serv=2&id=16#16 16 Mon, 01 Nov 2010 00:00:00 GMT The Publicly Funded Vaccines Market in the UK http://www.ohe.org/object/display.cfm?serv=2&id=19#19 19 Mon, 25 Oct 2010 23:00:00 GMT The Publicly Funded Vaccines Market in Australia http://www.ohe.org/object/display.cfm?serv=2&id=18#18 18 Mon, 25 Oct 2010 23:00:00 GMT Using QALYs in Cancer: Review of the Methodological Limitations http://www.ohe.org/object/display.cfm?serv=2&id=17#17 17 Mon, 25 Oct 2010 23:00:00 GMT New Drugs to Tackle Antimicrobial Resistance: Analysis of EU Policy Options http://www.ohe.org/object/display.cfm?serv=2&id=21#21 21 Tue, 05 Oct 2010 23:00:00 GMT Enhancing the Benefits from Spillovers http://www.ohe.org/object/display.cfm?serv=2&id=20#20 20 Thu, 30 Sep 2010 23:00:00 GMT US Healthcare Reform http://www.ohe.org/object/display.cfm?serv=2&id=22#22 22 Tue, 31 Aug 2010 23:00:00 GMT Innovation in Medicines: Can We Value Progress? http://www.ohe.org/object/display.cfm?serv=2&id=23#23 23 Sat, 31 Jul 2010 23:00:00 GMT Getting the Most out of PROMs http://www.ohe.org/object/display.cfm?serv=2&id=24#24 24 Mon, 01 Mar 2010 00:00:00 GMT Measuring Health Output, Productivity and Equity http://www.ohe.org/object/display.cfm?serv=2&id=25#25 25 Fri, 01 Jan 2010 00:00:00 GMT Access Mechanisms for Orphan Drugs http://www.ohe.org/object/display.cfm?serv=2&id=26#26 26 Sun, 01 Nov 2009 00:00:00 GMT Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective? http://www.ohe.org/object/display.cfm?serv=2&id=27#27 27 Wed, 30 Sep 2009 23:00:00 GMT How Fair? Competition between Independent and NHS Providers http://www.ohe.org/object/display.cfm?serv=2&id=29#29 29 Mon, 31 Aug 2009 23:00:00 GMT Forward Together: Complementarity of Public and Charitable Research http://www.ohe.org/object/display.cfm?serv=2&id=28#28 28 Mon, 31 Aug 2009 23:00:00 GMT Deliberative Processes in Decisions about Health Care Technologies http://www.ohe.org/object/display.cfm?serv=2&id=30#30 30 Sun, 31 May 2009 23:00:00 GMT American Exceptionalism and American Health Care http://www.ohe.org/object/display.cfm?serv=2&id=31#31 31 Mon, 02 Mar 2009 00:00:00 GMT The Impact of Health Technology Assessment on Drug Development http://www.ohe.org/object/display.cfm?serv=2&id=32#32 32 Sun, 01 Mar 2009 00:00:00 GMT Assessment and Appraisal of Oncology Medicines http://www.ohe.org/object/display.cfm?serv=2&id=33#33 33 Sun, 01 Feb 2009 00:00:00 GMT Compendium of Health Statistics http://www.ohe.org/object/display.cfm?serv=2&id=34#34 34 Sat, 31 Jan 2009 00:00:00 GMT Medical Research: What's It Worth? http://www.ohe.org/object/display.cfm?serv=2&id=36#36 36 Sat, 01 Nov 2008 00:00:00 GMT The Market for Biosimilars: Evolution and Policy Options http://www.ohe.org/object/display.cfm?serv=2&id=35#35 35 Sat, 01 Nov 2008 00:00:00 GMT New Guidelines for Economic Evaluation in Germany and the UK http://www.ohe.org/object/display.cfm?serv=2&id=37#37 37 Sat, 01 Nov 2008 00:00:00 GMT Challenges and Opportunities for Improving Benefit-Risk Assessment http://www.ohe.org/object/display.cfm?serv=2&id=38#38 38 Sun, 31 Aug 2008 23:00:00 GMT Sixty Years of the NHS http://www.ohe.org/object/display.cfm?serv=2&id=40#40 40 Sun, 31 Aug 2008 23:00:00 GMT Health Care Services and the Single European Market http://www.ohe.org/object/display.cfm?serv=2&id=39#39 39 Sun, 31 Aug 2008 23:00:00 GMT QALYs versus Experience: A Perspective from Experimental Economics http://www.ohe.org/object/display.cfm?serv=2&id=41#41 41 Thu, 31 Jul 2008 23:00:00 GMT NHS Outcomes, Performance and Productivity http://www.ohe.org/object/display.cfm?serv=2&id=42#42 42 Sat, 01 Mar 2008 00:00:00 GMT Estimating Pharmaceutical Companies' Value to the Nation http://www.ohe.org/object/display.cfm?serv=2&id=43#43 43 Fri, 02 Feb 2007 00:00:00 GMT Donor Investment Choices: Modeling the Value for Money http://www.ohe.org/object/display.cfm?serv=2&id=44#44 44 Sat, 02 Dec 2006 00:00:00 GMT Three Challenges to Achieving Better Analysis for Better Decisions http://www.ohe.org/object/display.cfm?serv=2&id=45#45 45 Sun, 01 Oct 2006 23:00:00 GMT Economic Post-Launch Studies: Matching the Desirable with the Feasible http://www.ohe.org/object/display.cfm?serv=2&id=46#46 46 Fri, 01 Sep 2006 23:00:00 GMT The Faces of Regulation: Profit and Price Regulation http://www.ohe.org/object/display.cfm?serv=2&id=47#47 47 Mon, 01 May 2006 23:00:00 GMT Health Systems Performance Assessment http://www.ohe.org/object/display.cfm?serv=2&id=48#48 48 Sat, 01 Apr 2006 23:00:00 GMT To Publish or Not? Hospital Outcomes Data http://www.ohe.org/object/display.cfm?serv=2&id=49#49 49 Thu, 31 Mar 2005 23:00:00 GMT The Many Faces of Innovation http://www.ohe.org/object/display.cfm?serv=2&id=50#50 50 Fri, 18 Feb 2005 00:00:00 GMT Activity Based Funding for Hospitals http://www.ohe.org/object/display.cfm?serv=2&id=51#51 51 Fri, 01 Oct 2004 23:00:00 GMT The Impact of Ageing on Health Care Expenditure http://www.ohe.org/object/display.cfm?serv=2&id=52#52 52 Sun, 01 Aug 2004 23:00:00 GMT How Much Should We Spend on the NHS? http://www.ohe.org/object/display.cfm?serv=2&id=53#53 53 Thu, 01 Jul 2004 23:00:00 GMT The Economics of Dental Care http://www.ohe.org/object/display.cfm?serv=2&id=54#54 54 Wed, 30 Jun 2004 23:00:00 GMT Developments in Economic Evaluation in Health Care: A Review of HEED http://www.ohe.org/object/display.cfm?serv=2&id=55#55 55 Tue, 02 Mar 2004 00:00:00 GMT Value Based Pricing in Sweden http://www.ohe.org/object/display.cfm?serv=2&id=122#122 122 Causes of Death in England and Wales http://www.ohe.org/object/display.cfm?serv=2&id=121#121 121 International Comparisons of Medicines Prices: 2011 Indices http://www.ohe.org/object/display.cfm?serv=2&id=120#120 120 The Many Faces of Innovation http://www.ohe.org/object/display.cfm?serv=2&id=119#119 119 Is There a Productivity Crisis in Pharmaceutical R&D? http://www.ohe.org/object/display.cfm?serv=2&id=118#118 118 The Use of Pay-for-Performance for Drugs http://www.ohe.org/object/display.cfm?serv=2&id=110#110 110 The Humble Economist: Collected Essays by Tony Culyer http://www.ohe.org/object/display.cfm?serv=2&id=123#123 123 The R&D Cost of a New Medicine http://www.ohe.org/object/display.cfm?serv=2&id=124#124 124 Valuing Health at the End of Life http://www.ohe.org/object/display.cfm?serv=2&id=125#125 125 Social Preferences About Unmet Need and Disease Severity http://www.ohe.org/object/display.cfm?serv=2&id=126#126 126 Projecting Expenditure on Medicines in the NHS http://www.ohe.org/object/display.cfm?serv=2&id=128#128 128 Valuing Orphan Medicines Using Multi-Criteria Decision Analysis http://www.ohe.org/object/display.cfm?serv=2&id=129#129 129 Exploring the Link Between Health and Wealth in Decision Making http://www.ohe.org/object/display.cfm?serv=2&id=130#130 130 Critical Review of Quality and Competition Measures in Health Care http://www.ohe.org/object/display.cfm?serv=2&id=109#109 109 Report of the OHE Commission on Competition in the NHS http://www.ohe.org/object/display.cfm?serv=2&id=108#108 108 Time Trends in NICE HTA Decisions http://www.ohe.org/object/display.cfm?serv=2&id=107#107 107 Childhood and Adolescent Mental Health http://www.ohe.org/object/display.cfm?serv=2&id=112#112 112 Assessing the Performance of the EQ-VAS in PROMs http://www.ohe.org/object/display.cfm?serv=2&id=114#114 114 The Tougher the Better: GP Performance Thresholds http://www.ohe.org/object/display.cfm?serv=2&id=115#115 115 The New Global Economics of Vaccines http://www.ohe.org/object/display.cfm?serv=2&id=116#116 116 Value Based Pricing and Molecular Diagnostics http://www.ohe.org/object/display.cfm?serv=2&id=117#117 117 Saving Lives, Buying Time: Economics of Malaria Drugs http://www.ohe.org/object/display.cfm?serv=2&id=113#113 113 The Effect of Free Personal Care for the Elderly on Informal Caregiving http://www.ohe.org/object/display.cfm?serv=2&id=127#127 127 Valuing Health at the End of Life http://www.ohe.org/object/display.cfm?serv=2&id=102#102 102 Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe http://www.ohe.org/object/display.cfm?serv=2&id=103#103 103 The Ideas and Influence of Alan Williams http://www.ohe.org/object/display.cfm?serv=2&id=104#104 104 Applied Econometrics for Health Economists http://www.ohe.org/object/display.cfm?serv=2&id=105#105 105 European Medicines Pricing and Reimbursement http://www.ohe.org/object/display.cfm?serv=2&id=106#106 106 What Could Be Nicer than NICE? http://www.ohe.org/object/display.cfm?serv=2&id=111#111 111